Physiotherapy in Exacerbation Chronic Obstructive Pulmonary Disease

University of Granada (UGR)

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease

Treatments: Other: Medical treatment; Other: Physiotherapy program+medical treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT01826682

DF0039UG

Details and patient eligibility

About

Chronic Obstructive Pulmonary Disease (COPD) is a chronic condition. Its evolution can be aggravated in some periods by an increase of the symptoms (above all the cough, the dyspnoea and the quantity of sputum purulence). This is known as exacerbation and it is the most frequent cause of hospital stay, urgences services and death in COPD. A physiotherapy program is carrying out in patients attending to the Hospital because of an exacerbation.

The hypothesis of this study is that a physiotherapy program added to a medical treatment increase the ventilatory function, the physiques variables, decrease depression and anxiety and improve the quality of life. Additionally, it is going to be assessed the effect of physiotherapy in time using phone calls and visits to the patient's home.

Full description

The benefits added to the respiratory physiotherapy and physical activity have been evidenced previously in the treatment of COPD. This justify the need of a short physiotherapy intervention program regarding to the hospital stay in exacerbation of COPD and a follow-up after the hospital stay.

4% of europeans have been reported to have medical intervention caused by respiratory exacerbation. 20% of these patients are patients with COPD. The mortality of COPD exacerbation is about 14% and 30% if mechanical ventilation is needed.

In order to that, it is very important to improve the quality of life and the recuperation of patients. It is relevant to mention the the high cost associated to this condition.

Enrollment: 58 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COPD diagnosis with exacerbation.
• No contraindication of physiotherapy.
• Signed written consent.
• Medical approval for inclusion.

Exclusion criteria

• Heart disease.
• Neurological patients.
• Contraindications of physiotherapy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

58 participants in 2 patient groups, including a placebo group

Medical treatment

Placebo Comparator group

Description:

29 people are being recruited in order to the inclusion criteria for the study. Placebo controlled.

Treatment:

Other: Medical treatment

Physiotherapy program+medical treatment

Active Comparator group

Description:

29 people are recruited in order to the inclusion criteria for the study. Experimental group

Treatment:

Other: Physiotherapy program+medical treatment